Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. TripAdvisor (TRIP) downgraded to Underperform from Market Perform at Cowen with analyst Kevin Kopelman citing a weak start to 2019, expectations for weaker usage, and worries about younger age demos using Google (GOOG). 2. Teva (TEVA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger citing his belief that the stock's premium valuation largely prices in expectations for upside in the coming quarters due to cost cutting and conservative Copaxone guidance. 3. VMware (VMW) downgraded to Sell from Neutral at Goldman Sachs, while Pivotal Software (PVTL) was downgraded to Neutral from Buy. 4. Ormat Technologies (ORA) downgraded to Neutral from Overweight at JPMorgan with the firm's analyst citing a lack of catalysts for share appreciation in 2019. 5. CSX (CSX) downgraded to Hold from Buy at Stifel with analyst Michael Baudendistel saying he no longer sees a solid reason why shares should outperform the market in the next twelve months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

UBS analyst Thomas Wadewitz lowered the firm's price target on CSX to $44 from $46 and keeps a Buy rating on the shares. CSX's Q1 EPS was modestly above consensus, showing improvement in the Purchased Services and Other expense line and providing positive commentary on their outlook for volumes, the analyst tells investors in a research note. The Q1 report was solid and CSX provided a constructive outlook, UBS contends.

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSBank... To see the rest of the story go to thefly.com. See Story Here